Lv1
40 积分 2024-03-18 加入
The rise of targeting chimeras (TACs): next-generation medicines that preempt cellular events
1个月前
已完结
Pyrazolopyridine: An efficient pharmacophore in recent drug design and development
3个月前
已完结
Rational Design and Optimization of a Novel Class of Macrocyclic Apoptosis Signal-Regulating Kinase 1 Inhibitors
3个月前
已完结
Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure
3个月前
已完结
Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors
3个月前
已完结
Rational approach to highly potent and selective apoptosis signal-regulating kinase 1 (ASK1) inhibitors
3个月前
已完结
Discovery of benzoheterocyclic-substituted amide derivatives as apoptosis signal-regulating kinase 1 (ASK1) inhibitors
3个月前
已完结
THU-187 Efficacy of the apoptosis-signal-regulating kinase 1 (ASK1) inhibitor SRT-015 in in vivo and in vitro pathogen-associated molecular patterns (PAMPs)-induced disease models
3个月前
已关闭
TOP-156 SRT-015: Novel therapeutic for cholestatic liver diseases
3个月前
已关闭
皖公网安备34019202002308
